Holdings Channel
Home Articles Latest Filings All Funds Stocks Being Bought Stocks Being Sold Insider Buying
Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
VRCA — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree VRCA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

VRCA — Performance
More Insider Buying
Other companies seeing insider buying close in time to when the Verrica Pharmaceuticals Insider Buying occurred are:

Astra Space Inc - Class A Insider Buying
Safety Shot Insider Buying
Merrimack Pharmaceuticals Insider Buying
Fate Therapeutics Insider Buying
HighPeak Energy Insider Buying
BlackRock MuniAssets Fund Insider Buying
Aspira Womens Health Insider Buying
StarTek Insider Buying
Precigen Insider Buying
First Savings Financial Group Insider Buying

Verrica Pharmaceuticals insider buying image
The table below summarizes the most recent Verrica Pharmaceuticals insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Verrica Pharmaceuticals insider buys are important for investors to follow.
DateInsiderPriceAmount
12-29-2023
Insider Buy		 PERCEPTIVE ADVISORS LLC
>10% Owner		 $7.17
CAGR » 		$2,305,132.24
321,616 shares
12-26-2023
Insider Buy		 PERCEPTIVE ADVISORS LLC
>10% Owner		 $6.45
CAGR » 		$3,256,191.48
504,652 shares
12-19-2023
Insider Buy		 PERCEPTIVE ADVISORS LLC
>10% Owner		 $5.63
CAGR » 		$6,941,716.31
1,233,931 shares
7-24-2023
Insider Buy		 Paul B. Manning
Director and >10% Owner		 $5.02
CAGR » 		$1,004,000.00
200,000 shares
7-11-2022
Insider Buy		 Christopher G. Hayes
Chief Legal Officer		 $3.40
CAGR » 		$25,500.00
7,500 shares
7-5-2022
Insider Buy		 PERCEPTIVE ADVISORS LLC
>10% Owner		 $2.10
CAGR » 		$2,999,999.10
1,428,571 shares
7-5-2022
Insider Buy		 Gary Goldenberg
Chief Medical Officer		 $2.10
CAGR » 		$49,998.90
23,809 shares
7-5-2022
Insider Buy		 Ted White
President and CEO		 $2.10
CAGR » 		$49,998.90
23,809 shares
7-5-2022
Insider Buy		 Christopher G. Hayes
Chief Legal Officer		 $2.10
CAGR » 		$11,999.40
5,714 shares
12-3-2021
Insider Buy		 Paul B. Manning
Director and >10% Owner		 $9.36
CAGR » 		$467,905.29
50,000 shares
6-4-2021
Insider Buy		 A. Brian Davis
Chief Financial Officer		 $9.89
CAGR » 		$49,450.00
5,000 shares
6-4-2021
Insider Buy		 Ted White
President and CEO		 $9.95
CAGR » 		$39,800.00
4,000 shares
6-4-2021
Insider Buy		 A. Brian Davis
Chief Financial Officer		 $9.89
CAGR » 		$49,450.00
5,000 shares
6-4-2021
Insider Buy		 Christopher G. Hayes
Chief Legal Officer		 $9.79
CAGR » 		$24,475.00
2,500 shares
6-4-2021
Insider Buy		 Ted White
President and CEO		 $9.95
CAGR » 		$39,800.00
4,000 shares
3-25-2021
Insider Buy		 Paul B. Manning
Director and >10% Owner		 $14.75
CAGR » 		$10,912,492.50
739,830 shares
8-25-2020
Insider Buy		 Craig Ballaron
Director		 $8.88
CAGR » 		$88,784.52
10,000 shares
8-20-2020
Insider Buy		 Paul B. Manning
Director and >10% Owner		 $9.09
CAGR » 		$181,800.00
20,000 shares
8-18-2020
Insider Buy		 Paul B. Manning
Director and >10% Owner		 $8.55
CAGR » 		$85,500.00
10,000 shares
8-17-2020
Insider Buy		 Paul B. Manning
Director and >10% Owner		 $6.92
CAGR » 		$41,520.00
6,000 shares
8-13-2020
Insider Buy		 Ted White
President and CEO		 $6.28
CAGR » 		$66,951.08
10,661 shares
8-13-2020
Insider Buy		 A. Brian Davis
Chief Financial Officer		 $6.24
CAGR » 		$49,296.00
7,900 shares
8-14-2020
Insider Buy		 Sean Stalfort
Director		 $6.41
CAGR » 		$200,463.50
31,250 shares
8-14-2020
Insider Buy		 Paul B. Manning
Director and >10% Owner		 $6.44
CAGR » 		$1,020,985.00
158,500 shares
10-10-2019
Insider Buy		 Paul B. Manning
Director and >10% Owner		 $14.38
CAGR » 		$300,279.84
20,886 shares
1-7-2019
Insider Buy		 Paul B. Manning
Director and >10% Owner		 $11.18
CAGR » 		$530,811.18
47,500 shares
1-7-2019
Insider Buy		 Sean Stalfort
Director		 $10.45
CAGR » 		$96,385.98
9,221 shares
8-20-2018
Insider Buy		 Ted White
President and CEO		 $16.36
CAGR » 		$4,908.00
300 shares
6-19-2018
Insider Buy		 PERCEPTIVE ADVISORS LLC
>10% Owner		 $15.00
CAGR » 		$15,000,000.00
1,000,000 shares

Also See: Institutional Holders of VRCA
Also See: SEC filings

VRCA Performance Since Insider Purchase
Below we present the annualized performance delivered by Verrica Pharmaceuticals stock since 12-29-2023 (the date of the most recent insider purchase). The performance of the investment from the time Verrica Pharmaceuticals insider buying occurred is the ultimate test of whether insiders were right about VRCA being a good buy.

Growth of $10,000.00
Without Dividends Reinvested
Start date: 01/02/2024
End date: 05/01/2024
Start price/share: $6.81
End price/share: $6.85
Dividends collected/share: $0.00
Total return: 0.59%
Annualized Gain: 1.80%
Starting investment: $10,000.00
Ending investment: $10,059.00
Years: 0.33

Verrica Pharmaceuticals Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Verrica Pharmaceuticals insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding VRCA

Verrica Pharmaceuticals Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.